Section Arrow
BRVE.NASDAQ
- Braveheart Bio Inc.
Quotes are at least 15-min delayed:2026/08/07 12:56 EDT
Regular Hours
Last
 30.17
+0.37 (+1.24%)
Day High 
31.2 
Prev. Close
29.8 
1-M High
31.5581 
Volume 
287.57K 
Bid
30.16
Ask
30.34
Day Low
28.465 
Open
29.7 
1-M Low
29.415 
Market Cap 
-- 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High 31.5581 
52-W Low 29.415 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
--/--
Enterprise Value
--
Balance Sheet
Book Value Per Share
N/A
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CELZCreative Medical Technology Holdings1.33+0.18+15.65%-- 
IOVAIovance Biotherapeutics5.97-0.24-3.86%-- 
ARDXArdelyx4.02-0.85-17.45%-- 
ENSCEnsysce Biosciences0.5098-0.0145-2.77%-- 
REPLReplimune Group12.29-0.57-4.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.